MYRIAD GENETICS INC Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q2 2010 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Myriad Genetics Inc quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q2 2010 to Q4 2023.
  • Myriad Genetics Inc Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $95M, a 124% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $95M +$52.6M +124% Dec 31, 2023 10-K 2024-02-28
Q4 2022 $42.4M +$3.9M +10.1% Dec 31, 2022 10-K 2024-02-28
Q4 2021 $38.5M -$3.5M -8.33% Dec 31, 2021 10-K 2023-03-01
Q4 2020 $42M Dec 31, 2020 10-K 2022-02-25
Q2 2020 $42.4M +$3.5M +9% Jun 30, 2020 10-KT 2021-03-16
Q2 2019 $38.9M +$1.1M +2.91% Jun 30, 2019 10-KT 2021-03-16
Q2 2018 $37.8M -$2.7M -6.67% Jun 30, 2018 10-K 2019-08-13
Q2 2017 $40.5M +$4.9M +13.8% Jun 30, 2017 10-K 2018-08-24
Q2 2016 $35.6M +$2.2M +6.59% Jun 30, 2016 10-K 2017-08-09
Q2 2015 $33.4M -$8M -19.3% Jun 30, 2015 10-K 2016-08-10
Q2 2014 $41.4M +$33.2M +404% Jun 30, 2014 10-K 2015-08-12
Q2 2013 $8.22M +$1.61M +24.3% Jun 30, 2013 10-K 2014-08-13
Q2 2012 $6.61M +$1.85M +38.9% Jun 30, 2012 10-K 2013-08-14
Q2 2011 $4.76M -$35M -88% Jun 30, 2011 10-K 2012-08-15
Q2 2010 $39.8M Jun 30, 2010 10-K 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.